Pfizer Articles
Data on withdrawn drugs was faked; says hospital
16 March 2009
$60M exit package for S-P CEO Hassan?
16 March 2009
MannKind buys Pfizer insulin facility
16 March 2009
White House summit: PhRMA in, BIO out
16 March 2009
Xencor licenses Ab technology to Pfizer
9 March 2009
Pfizer and B&L to co-promote ophthalmics
9 March 2009
Pfizer "regrets offense" over demo photos
9 March 2009
China
9 March 2009
Agility and innovation, at Economist
9 March 2009
Four Novartis drugs and B-MS
9 March 2009
NicOx "on the brink" of becoming a drugmaker
9 March 2009
AZ's sub-group analysis supports Crestor data
2 March 2009
Analysts expect profit for Theravance in 2012
2 March 2009
Llamas way forward for antibody drugs
23 February 2009
Stock Commentary - Europe - week to Feb 16, 2009
23 February 2009
Sweden's TLV rejects 1st-line use of Pfizer's Lipitor, cites "20 times" cost differential
23 February 2009
Drugmakers remain attractive employers in Belgium
23 February 2009
Synta names Pfizer's Vojo Vukovic as VP of clinical research
16 February 2009
ED drugmakers accused of price-fixing in Switzerland
16 February 2009
Pfizer to publicize payments to health professionals
16 February 2009
Crucell back in profit as Wyeth deal collapses
16 February 2009
Sutent available in England, not Scotland
9 February 2009
JN to acquire Pfizer's Omaha vaccine plant
9 February 2009
Stock Commentary - New York week to Feb 2, 2009
9 February 2009
Lilly swings to loss on ImClone acquisition
9 February 2009
Lexapro and Zoloft are "best" antidepressants
9 February 2009
Retail drug sales in year to November 2008
26 January 2009
Pfizer uses fake drug shock tactics in the UK
26 January 2009
More job cuts among Big Pharma firms
26 January 2009
Another US approval delay for Pfizer's Fablyn
26 January 2009
Emergency listing of HIV drugs in Japan
26 January 2009
Highlights of first PDCO meeting of 2009
26 January 2009
Pfizer to divest 100 products and cut 800 jobs worldwide
19 January 2009
Stock Commentary - Europe - week to Jan 19, 2009
19 January 2009
Satori raises $22M; ex-Pfizer senior VP named CEO
19 January 2009
GSK/XenoPort resubmit NDA in RLS
19 January 2009
Pharma/biotech mergers and acquisitions in 2008
12 January 2009
GSK to stop making political donations
12 January 2009
Cytos shares jump 15.6% as Pfizer options immunodrug technology
12 January 2009
Pfizer gets clarified Lipitor patent
12 January 2009
CEO says Pfizer is open to "mega-merger"
12 January 2009
Pfizer's Fablyn gets nod from CHMP
12 January 2009
RAND model finds Rx price controls would cost more in terms of shorter life expectancy
12 January 2009
Pfizer licenses ZFN tech from Sangamo
12 January 2009
Pfizer licenses Novocell's progenitor cells
12 January 2009
Drugmakers fund Clinton foundation
12 January 2009
Wyeth buys UK biotech Thiakis for $150M
12 January 2009
Three drug majors announce lay-offs in midst of credit-crunch
22 December 2008
Anti-epileptics to get suicide warnings in USA
22 December 2008
Pfizer's Aromasin boosts DFS 11% in early breast cancer
22 December 2008
French unions protest pharma job cuts
22 December 2008
Pfizer takes full rights to Exubera for $1.3B
22 December 2008
Crisis in CEE pharma innovative market
22 December 2008
Retail drug sales in year to October 2008
22 December 2008
New US DTC guidelines from PhRMA dismissed by leading Democrats
22 December 2008
US insurer cuts Lipitor co-pay by up to 50%
15 December 2008
Pfizer in deal to market Eurartesim in Africa
15 December 2008
Pfizer study bites back against claims generic CV drugs just as effective as branded
15 December 2008
Lipitor moves to preferred brand on CIGNA's Rx drug list
15 December 2008
Japan's doctors want new drugs developed
8 December 2008
Pfizer's Selzentry granted full US approval
8 December 2008
Boehringer opens new Japanese R&D center
1 December 2008
SCS signs UK stem cell deal with Pfizer
1 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
Major fake drug hauls in France, seized in transit
1 December 2008
Pfizer to spend $60M on UK stem cell unit
24 November 2008
Solvay discontinues CB1 obesity drug SLV319
24 November 2008
Stock Commentary - Europe - week to Nov 17, 2008
24 November 2008
MNCs could gain from low Indian drug prices
17 November 2008
GSK/XenoPort withdraw Solzira filing
17 November 2008
Wuxi enters three-year ADME analysis accord with Pfizer
17 November 2008
Negative press has compromised Vytorin as first-line therapy; DR
17 November 2008
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
